MedQIA utilizes cuttting edge computer vision technology to deliver novel imaging biomarkers that are objectively measured and evaluated. Imaging biomarkers provide early evidence of therapeutic efficacy for accelerated drug development. They provide predictive power for targeted therapies and improved patient outcomes - "who should be treated, with what and when".

MedQIA is your one stop for all aspects of imaging biomarker development and core lab services. Our multidisciplinary laboratory includes imaging physics, computer vision, biostatistics, and radiology. Our team provides world-wide support through an online clinical trial management system.